Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer.

OBJECTIVE: To analyze the expression of the antiapoptotic gene bcl-xL in human pancreatic cancer and to correlate the results with clinical patient parameters. SUMMARY BACKGROUND DATA: Bcl-xL belongs to the bcl-2-related gene family and acts as a broad antiapoptotic factor to extend both normal and...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Friess, H, Lu, Z, Andrén-Sandberg, A, Berberat, P, Zimmermann, A, Adler, G, Schmid, R, Büchler, M W
Format: Artigo
Langue:Inglês
Publié: 1998
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1191596/
https://ncbi.nlm.nih.gov/pubmed/9860477
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires